6010. Slim-Drin tablets.    (F.D.C. No. 43294.    S. No. 56-799 P.)
QUANTITY: 12,000 tablets in bulk drum, and 204 25-tablet btls, and 36 100- 
tablet btls., at Hollywood, Fla., in possession of Vishy Drug Products.
SHIPPED :   3-31-59, from Philadelphia, Pa., by Richlyn Laboratories.
LABEL IN PART: (Drum) "Phenylpropanolamine HCL 25 Mg. * * * Richlyn 
Laboratories, Philadelphia 24, Pa."; (btl.) "Slim-Drin Appetite Depressant 
Vishy Drug Products Hollywood Florida Distributor Directions: * * * 
Each tablet contains Phenylpropanolamine Hydrochloride 25 mgm. Caution: 
* * * Control No. 604."
ACOOMPANTING LABELING: (Display ctn.) "Slim-Drin For Appetite Control 
Just released by the Federal Government for overcounter sale."
RESULTS OF INVESTIGATION :   The display cartons were purchased as blank cartons
by the dealer and printed as needed. 
The article in the bottles was repackaged by the dealer from the tablets in the
bulk drum which were shipped as described above. 
LIBELED : 7-9-59, S. Dist. Fla.
CHARGE : 502 (a)-(drum) when shipped, the drum label of the article contained 
false and misleading representations that the article was adequate and effec- 
tive for controlling the appetite in the management of obesity, and that it 
was an adequate and effective treatment for relieving asthma and bronchial 
spasm of the allergic type; and, while held for sale, the name "Slim-Drin" and 
certain statements on the bottle label and on the display carton contained
?See also Nos. 6001, 6004-6006, 6008.
false and misleading representations that the article was an adequate and 
effective treatment in controlling appetite, and causing one to lose weight 
immediately without tough diets; and, in addition, the display cartons con- 
tained statements that the article had just been released by the Federal 
Government for over the counter sale and that the article contained no harm- 
ful drugs, which statements were false and misleading since it contained the 
drug phenylpropanolamine which is not a harmless drug; certain precautions 
must be observed in its use; and such drug had not been "just released" but 
has been available for sale without prescription for a number of years under 
labeling which contains appropriate restrictions on the dosage and with 
caution against use by individuals with high blood pressure, heart disease, 
diabetes, and thyroid disease, except as directed by a physician.
DISPOSITION: 11-10-59.   Default-destruction.